Insights On Upstream Manufacturing
-
Enhanced Validation Data Anti-EGFRvIII Recombinant Antibody
3/24/2025
Select the right antibody clone by exploring enhanced validation data for top recombinant antibody clones that offer comprehensive specificity and sensitivity insights tailored to your project's unique requirements.
-
MilliporeSigma Bio-Expo Live February 2025: Upstream Bioprocessing
3/18/2025
Review the benefits of implementing a closed and sterile sampling system, such as NovaSeptum®, to improve sampling procedures and meet regulatory expectations.
-
Streamline The Path To FIH Trials With Advanced Cell Line Development
3/18/2025
Many CDMOs cannot handle complex recombinant proteins, which often require a CLD process fully integrated with other CDMO components, including analytics and formulation development.
-
Is Sustainability The Key To Agile Biopharma Manufacturing?
3/18/2025
In biologics manufacturing, change is constant. Discover how new innovations and a focus on sustainability have gotten 62% of executives to prioritize eco-friendly practices, which reflects a commitment to long-term viability.
-
Mirus Bio Bio-Expo Live February 2025: Upstream Bioprocessing
3/17/2025
AAV vector manufacturing is a bottleneck in cell and gene therapy. Watch to learn about a new transfection platform that boosts AAV titers and percent-full capsids to help simplify production workflows.
-
Regulatory Frameworks For mRNA Therapeutics
3/17/2025
The RNA therapeutics and vaccines market has grown rapidly, driven by siRNA and mRNA technologies. Explore how these advancements are now being applied to cancer vaccines and innovative therapeutics.
-
Automation Of iPSC Culture, Passaging, And Expansion
3/17/2025
Find out how iPSC-derived models enable researchers to generate diverse cell types and tissues as well as how automation reduces the labor-intensive culturing process with AI-powered decision-making.
-
Automation Of 3D Intestinal Organoids Culture
3/17/2025
Gain insight into how 3D organoids promise better disease modeling and drug screening and how challenges like assay complexity, reproducibility, and scalability hinder their widespread adoption in drug discovery.
-
Rapid Automated Selection Of Mammalian Cell Colonies
3/17/2025
Discover how a new technology cultivates mammalian cells into clonal colonies and images them using fluorescent assays to isolate clonal cell populations based on surface protein expression.
-
Boehringer Ingelheim Large Scale Cell Culture Facility
3/14/2025
With cutting-edge innovations like smart glasses for live process insights and a data-sharing portal, we're able to provide the capacity and expertise to bring biologics to commercial success.